# A Study of Angiotensin-II Receptor Blocker on Cardiovascular Remodeling (VALUE Trial)

Study · id `cardio:ct-nct06150560` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06150560](<https://clinicaltrials.gov/study/NCT06150560>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06150560

Browse, organ or system: Heart; Blood vessels  
Browse, condition area: High blood pressure; Valve and congenital heart disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 120 participants.

## Technical summary

Registry record NCT06150560. Randomized; double masking; primary purpose supportive care. Start 2024-04-01 (actual); primary completion 2028-06-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose supportive care
- Phase: Phase 3
- Enrolled: 120 participants (planned count; ClinicalTrials.gov record NCT06150560, source copy `cardio:ctgov-nct06150560-2026-09-11`, retrieved 2026-10-26)
- Started: 2024-04-01 (actual) (ClinicalTrials.gov record NCT06150560, source copy `cardio:ctgov-nct06150560-2026-09-11`, retrieved 2026-10-26)
- Primary completion: 2028-06-01 (anticipated) (ClinicalTrials.gov record NCT06150560, source copy `cardio:ctgov-nct06150560-2026-09-11`, retrieved 2026-10-26)
- Completion: 2028-06-01 (anticipated) (ClinicalTrials.gov record NCT06150560, source copy `cardio:ctgov-nct06150560-2026-09-11`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT06150560, source copy `cardio:ctgov-nct06150560-2026-09-11`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06150560-2026-09-11`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Study of Angiotensin-II Receptor Blocker on Cardiovascular Remodeling (VALUE Trial)
- Acronym: VALUE
- Condition: Coarctation of Aorta
- Condition: High Blood Pressure
- Intervention (Drug): Losartan
- Intervention (Drug): Amlodipine
- Intervention (Drug): Placebo
- Lead sponsor: Mayo Clinic
- Lead sponsor class: OTHER
- Collaborator: National Heart, Lung, and Blood Institute (NHLBI)
- Collaborator class: NIH

## Connected pages

- Registry condition terms include this condition: Adult congenital heart disease (`cardio:adult-congenital-heart-disease`)
- Registry condition terms include this condition: Coarctation of the aorta (`cardio:coarctation-of-the-aorta`)
- Registry condition terms include this condition: Congenital heart disease (`core:congenital-heart-disease`)
- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry intervention name matches this record: Losartan (`cardio:losartan`)
- Registry intervention name matches this record: Amlodipine (`cardio:amlodipine`)
- Registry lists this organization as the lead sponsor: Mayo Clinic (`cardio:org-mayo-clinic`)
- Registry lists this organization as a collaborator: National Heart, Lung, and Blood Institute (`cardio:nhlbi`)

## Provenance

Content hash: eda64a17359840687359cddce3ff3d4773f620972fbe509b7c9dfaec3164c75d
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
